Creative Planning’s Kite Pharma, Inc. KITE Stock Holding History

Creative Planning’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-500	Closed	-$33K	–	4522
2017 Q2	$33K	Sell	500 -500	-50%	-$40.8K	﹤0.01%	2839
2017 Q1	$42K	Sell	1,000 -500	-33%	-$30.9K	﹤0.01%	2613
2016 Q4	$40K	Buy	1,500 +500	+50%	+$24.5K	﹤0.01%	2576
2016 Q3	$10K	Buy	+1,000	New	+$55.7K	﹤0.01%	3555

Creative Planning's KITE Position: Q4 2017 in Review

Creative Planning sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 1,978 shares — an estimated $356K sold.

Creative Planning first reported a position in KITE in Q4 2014 and held it in 11 quarters. The position peaked at $1.56M in Q4 2014. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

Creative Planning reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
Creative Planning sold 1,978 Kite Pharma, Inc. shares in Q4 2017, an estimated $356K.
Creative Planning first reported a position in Kite Pharma, Inc. in Q4 2014 and held it in 11 quarters.
Creative Planning's Kite Pharma, Inc. position peaked at $1.56M in Q4 2014.
0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Creative Planning's 13F filing for Q4 2017, filed 17 Jan 2018.